HEPCARE EUROPE NEWSLETTER B r id g in g th e Ga p in th e Tr e a tm e n t o f H e p a ti tis C
Newsletter Date
Project Launch
Issue 1, Nov 2016
The launch of Hepcare Europe took place in Dublin, as coordinating site, on 22nd June 2016. The event was attended by VIP guests from the HSE, Ireland East Hospital Group, HRB, and leading clinicians from the infectious diseases field, as well as other key stakeholders in Hepatitis C care in Ireland. The audience listened to a series of informative talks on HCV treatment from a
multidisciplinary panel of presenters. Dr Graham Love, Chief Executive of the Health Research Board (HRB) said: “Infectious diseases such as hepatitis C transcend borders and Irish citizens will derive real
treatment benefit from projects like HepCare Europe.” Pictured below from left to right: Dr Lambert (UCD/ MMUH), Dr Hiney (HRB), Prof Day (Ireland East Hospital Group), Ms Tait (HSE), Prof Cullen (UCD), Ms Perry (Community Response)
Hepcare Europe Events ·
Seminar with NGO’s dedicated to homeless people, 7th July, 2016, Seville.
·
Industry lecture on HCV in PWID and other drug users, 20th Oct, 2016, Seville.
·
Peer Training Day, 2nd November, 2016, London.
·
Steering Group meeting, 9th Nov, 2016, Bristol.
·
Stakeholder Meeting , 24th Nov, 2016 & 19th Jan, 2017, Dublin
·
Masterclass 3 ‘Role of the Peer Educator’ Wed 30th Nov 2016, Dublin.
Inside this issue: Launch
1
Points of interest
1
Events
1
Site Introduction
2
In the community
2
Contact details
2
Special points of interest: · Dublin team met with Michele Tait (National Coordinator, HSE) to discuss partnerships · Several Hepcare Europe abstracts have been submitted to EASL Conference, 19th23rd April, Amsterdam. · Seville team are in the process of scheduling their first Hepcare Europe Masterclass.
HEPCARE EUROPE SITES UCD –MMUH—Dublin –Ireland SAS– Seville– Spain SVB– Bucharest- Romania UoB– Bristol– UK Phone: +353 1 716 4562 Fax: +353 1 716 4537 E-mail:
[email protected];
[email protected];
Site Introduction Hepcare Europe is an EU Third Health Programme co-funded project involving 5 sites. University College Dublin (UCD), Ireland, are the coordinating organization supported by the Mater Misericordiae University Hospital, (MMUH), Dublin. The other clinical sites are Servicio Andaluz de Salud (SAS) in partnership with FISEVI in Spain.; Spitalul Clinic Dr Victor Babes Bucuresti (SVB) in Romania, and University College London (UCL). University of Bristol (UoB) will be a non clinical site involved in carrying out a cost effectiveness evaluation of the project.
BRIDGING THE GAP IN THE TREATMENT OF HEPATITIS C Website: www.ucd.ie/ medicine/hepcare/ Twitter: @HepcareE
Hepcare Europe in the Community We are implementing a community based integrated care model for the treatment of HCV to facilitate diagnosis and screening of vulnerable and marginalised groups with HCV in the community. This involves a liaison nurse using a novel Fibroscan test to evaluate patients’ HCV status in general practices, addiction clinics, and prisons, with the aim to improve the currently suboptimal level of referrals to secondary care. The project vision is to increase joint participation of primary and speciality care practitioners to allow for more efficient use of limited specialist resources and improve access to the new Direct Acting Antiviral drugs for patients with Hepatitis C.
Co-funded by the Health Programme of the European Union
